Pre-Clinical Research Request for Applications

Spinal Research and The Christopher & Dana Reeve Foundation have partnered to fund pre-clinical research applications on paralysis caused by traumatic spinal cord injury in support of the mission of both organisations.

2-Image Side-by-Side Section

A downloadable PDF of the Pre-clinical Request for Applications Overview & Guide is available on the application portal. Visit the portal to access and review the guide in full.

Apply now >

Informational webinar

An informational webinar will be held on November 12, 2024 at 4PM GMT to clarify and explain the goals of this RFA and answer applicant questions. The webinar will be available to view on-demand after the live air date.

Click here to register >

Request for Application (RFA) Overview

A critical step in the translational pipeline is that between discovery and Investigational New Drug (or Investigational Device) enabling studies. Therefore, this request for applications (RFA) encompasses early pre-clinical (non-human) to translational research to support pre-IND or pre-IDE studies in traumatic spinal cord injury (SCI)

Our goal is to promote an understanding of a proposed therapeutic that will encourage continued engagement and support to prepare for the next stages of scientific research and development. Studies of new or repurposed drugs and biologics, and non-clinical research for medical devices, gene therapy approaches, of neuroprotection, regeneration and plasticity are within the scope of the RFA. Full drug screens, IND enabling studies or clinical research are outside the scope of this RFA.

Deadlines

Please note: Applicants are encouraged to apply early in the event of issues with the submission process. Program staff will be unable to respond to queries in the two days prior to an application deadline; all queries must be sent prior to that time. Please do not request updates from program staff prior to timelines delineated above.

2-Column Section with Full-Width Text and Single-Line Buttons

Pre-Clinical Research RFA Description

This RFA supports pre-clinical (non-human) research of new or repurposed drugs and biologics in the areas of neuroprotection, regeneration and plasticity, at the pre-IND or pre-IDE development stage.

Find out more >

Letter of intent (LOI) submission process

This RFA will be a two-stage process with an initial LOI submissions and review followed by an invitation- only full grant application process.

Find out more >

How your money helps

With you generosity we are able to fund groundbreaking research with the power to transform lives.

Read more

Spinal Research and Reeve Foundation announce joint international research call.

Read more

Donate

Your generous donation today will make a real difference, helping us drive forward vital research.

Read more